In vivo imaging of transgenic Brugia malayi.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
02
01
2020
accepted:
28
02
2020
entrez:
4
4
2020
pubmed:
4
4
2020
medline:
7
7
2020
Statut:
epublish
Résumé
Studies of the human filarial parasite have been hampered by the fact that they are obligate parasites with long life cycles. In other pathogenic infections, in vivo imaging systems (IVIS) have proven extremely useful in studying pathogenesis, tissue tropism and in vivo drug efficacy. IVIS requires the use of transgenic parasites expressing a florescent reporter. Developing a method to produce transgenic filarial parasites expressing a florescent reporter would permit IVIS to be applied to the study of tissue tropism and provide a non-invasive way to screen for in vivo drug efficacy against these parasites. We report the development of a dual luciferase reporter construct in a piggyBac backbone that may be used to stably transfect Brugia malayi, a causative agent of human filariasis. Parasites transfected with this construct were visible in IVIS images obtained from infected gerbils. The signal in these infected animals increased dramatically when the transgenic parasites matured to the adult stage and began to produce transgenic progeny microfilaria. We demonstrate that the IVIS system can be used to develop an effective method for cryopreservation of transgenic parasites, to non-invasively monitor the effect of treatment with anti-filarial drugs, and to rapidly identify transgenic F1 microfilariae. To our knowledge, this represents the first application of IVIS to the study of a human filarial parasite. This method should prove useful in studies of tissue tropism and as an efficient in vivo assay for candidate anti-filarial drugs.
Sections du résumé
BACKGROUND
Studies of the human filarial parasite have been hampered by the fact that they are obligate parasites with long life cycles. In other pathogenic infections, in vivo imaging systems (IVIS) have proven extremely useful in studying pathogenesis, tissue tropism and in vivo drug efficacy. IVIS requires the use of transgenic parasites expressing a florescent reporter. Developing a method to produce transgenic filarial parasites expressing a florescent reporter would permit IVIS to be applied to the study of tissue tropism and provide a non-invasive way to screen for in vivo drug efficacy against these parasites.
METHODOLOGY/PRINCIPAL FINDINGS
We report the development of a dual luciferase reporter construct in a piggyBac backbone that may be used to stably transfect Brugia malayi, a causative agent of human filariasis. Parasites transfected with this construct were visible in IVIS images obtained from infected gerbils. The signal in these infected animals increased dramatically when the transgenic parasites matured to the adult stage and began to produce transgenic progeny microfilaria. We demonstrate that the IVIS system can be used to develop an effective method for cryopreservation of transgenic parasites, to non-invasively monitor the effect of treatment with anti-filarial drugs, and to rapidly identify transgenic F1 microfilariae.
CONCLUSIONS
To our knowledge, this represents the first application of IVIS to the study of a human filarial parasite. This method should prove useful in studies of tissue tropism and as an efficient in vivo assay for candidate anti-filarial drugs.
Identifiants
pubmed: 32243453
doi: 10.1371/journal.pntd.0008182
pii: PNTD-D-19-02153
pmc: PMC7122700
doi:
Substances chimiques
DNA Transposable Elements
0
Luciferases
EC 1.13.12.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008182Subventions
Organisme : NIAID NIH HHS
ID : R21 AI135172
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Acta Trop. 1990 May;47(4):223-6
pubmed: 1973024
Am J Trop Med Hyg. 1983 Jul;32(4):767-71
pubmed: 6683940
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005163
pubmed: 28056015
PLoS Negl Trop Dis. 2018 May 21;12(5):e0006509
pubmed: 29782496
Methods Mol Biol. 2013;940:103-15
pubmed: 23104337
Am J Trop Med Hyg. 2019 Dec;101(6):1312-1321
pubmed: 31595865
Parasitology. 2014 Jan;141(1):119-27
pubmed: 23866958
Mem Inst Oswaldo Cruz. 2006 May;101(3):269-72
pubmed: 16862320
Exp Parasitol. 1992 May;74(3):315-23
pubmed: 1582484
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16026-31
pubmed: 21896745
Am J Trop Med Hyg. 2001 Aug;65(2):162-3
pubmed: 11508394
PLoS Negl Trop Dis. 2010 Mar 09;4(3):e625
pubmed: 20231890
Mol Biochem Parasitol. 2004 Sep;137(1):23-33
pubmed: 15279948
FEBS J. 2016 Sep;283(17):3204-21
pubmed: 27300487
J Mol Biol. 2005 Oct 14;353(1):1-13
pubmed: 16154590
Southeast Asian J Trop Med Public Health. 1991 Jun;22(2):165-7
pubmed: 1948273
Methods Mol Biol. 2020;2081:81-106
pubmed: 31721120
Parasit Vectors. 2015 Oct 22;8:552
pubmed: 26489937
Parasitol Res. 2014 May;113(5):1827-35
pubmed: 24664084
Ciba Found Symp. 1987;127:225-35
pubmed: 3595322
Expert Rev Vaccines. 2017 Jul;16(7):1-13
pubmed: 28525963
J Vis Exp. 2010 Jul 27;(41):
pubmed: 20689512
PLoS Negl Trop Dis. 2011 Dec;5(12):e1409
pubmed: 22180794
PLoS Negl Trop Dis. 2019 Jan 16;13(1):e0006320
pubmed: 30650105
Int J Parasitol. 2008 Aug;38(10):1111-9
pubmed: 18364245
J Exp Med. 1991 Mar 1;173(3):659-63
pubmed: 1997651
PLoS Negl Trop Dis. 2019 Jul 1;13(7):e0007556
pubmed: 31260456
Bull World Health Organ. 2002;80(5):384-91
pubmed: 12077614
Clin Infect Dis. 2019 Oct 23;:
pubmed: 31641754
Mol Biochem Parasitol. 2012 Nov;186(1):38-43
pubmed: 23017214
Biochemistry (Mosc). 2015 Jun;80(6):701-13
pubmed: 26531016